pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

14,268 catalysts · 3,350 8k filing · 2,402 grant · 2,350 approval · 1,681 device 510k · 1,204 device recall · 1,151 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 66 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-02×clear all
type
  • 8k filing3,350
  • grant2,402
  • approval2,350
  • device 510k1,681
  • device recall1,204
  • device pma1,151
device adverse event
1,000
  • earnings584
  • recall465
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Oct 20, 2025

    50
    ›Oct 22, 2025device pma297d agoAbbott Vascular — XIENCE Alpine™ Everolimus Eluting Coronary Stent System (XIENCE Alpine OTW) (PMA supplement)Postsurgical Therapeutics Inc

    Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoMedtronic, Inc. — Medtronic Evolut™ PRO+ Delivery Catheter System (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoBoston Scientific — L110 ESSENTIO™ MRI SR,L111 ESSENTIO™ MRI DR,L131 ESSENTIO™ MRI EL DR,L210 PROPONENT,L211 PROPONENT,L231 PROPONENT,L310 A (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: LWP. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoLimFlow, Inc. — LimFlow System (PMA supplement)

    Supplement type: Real-Time Process. Product code: QWN. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoCook Ireland, Ltd. — Zilver Flex® 35 Vascular Stent (PMA supplement)

    Supplement type: Special (Immediate Track). Product code: NIO. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoEndotronix, Inc. — Cordella Pulmonary Artery Sensor System (CorPASS) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MOM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoAbbott Vascular, Inc. — Absolute Pro Vascular (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIO. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoOn-X Life Technologies, Inc. — On-X Prosthetic Heart Valves and Ascending Aortic Prothesis (AAP) (PMA supplement)Lifeloc Technologies, Inc

    Supplement type: 30-Day Notice. Product code: LWQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoTransMedics, Inc. — Organ Care System™ (OCS™) Lung System (PMA supplement)TransMedics Group, Inc.

    Supplement type: 30-Day Notice. Product code: QBA. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoBoston Scientific — D010 INOGEN™ MINI ICD VR, D011 INOGEN™ MINI ICD VR, D012 INOGEN™ MINI ICD DR, D013 INOGEN™ MINI ICD DR, D020 DYNAGEN™ MI (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoOn-X Life Technologies, Inc. — On-X Prosthetic Heart Valves and Ascending Aortic Prothesis (PMA supplement)Lifeloc Technologies, Inc

    Supplement type: 30-Day Notice. Product code: LWQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoTransMedics, Inc. — Organ Care System™ (OCS™) Liver (PMA supplement)TransMedics Group, Inc.

    Supplement type: 30-Day Notice. Product code: QQK. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoBoston Scientific Corporation — A209 SICD Gen 2,A219 SICD MRI (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoInspire Medical Systems — Inspire® Upper Airway Stimulation (PMA supplement)Inspire Medical Systems, Inc.

    Supplement type: Normal 180 Day Track No User Fee. Product code: MNQ. Advisory committee: AN. Decision: APPR

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoBoston Scientific — D010 INOGEN™ MINI ICD VR,D011 INOGEN™ MINI ICD VR,D012 INOGEN™ MINI ICD DR,D013 INOGEN™ MINI ICD DR,D020 DYNAGEN™ MINI I (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoQIAGEN GmbH — therascreen® PIK3CA RGQ PCR Kit (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: OWD. Advisory committee: MG. Decision: APPR

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoBoston Scientific Corp — G124 MOMENTUM™ CRT-D,G125 MOMENTUM™ CRT-D,G126 MOMENTUM™ CRT-D,G128 MOMENTUM,G138 MOMENTUM™ X4 CRT-D,G140 INOGEN™ CRT-D, (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: 30-Day Notice. Product code: NIK. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoOn-X Life Technologies, Inc. — On-X Prosthetic Heart Valves; On-X Ascending Aortic Prothesis (PMA supplement)Lifeloc Technologies, Inc

    Supplement type: 30-Day Notice. Product code: LWQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device pma297d agoOn-X Life Technologies, Inc. — On-X Heart Valve; On-X Ascending Aortic Prosthesis (PMA supplement)Lifeloc Technologies, Inc

    Supplement type: 30-Day Notice. Product code: LWQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat 5 mm, 45 cm, Front-Actuated Grip Type S — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat, 5mm, 35 cm, Pistol Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat 5 mm, 20 cm, Front-Actuated Grip Type S — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat, 5 mm, 20 cm, Inline Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat 5 mm, 35 cm, Front-Actuated Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat, 5 mm, 45 cm, Pistol Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat 5 mm, 10 cm, Inline Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoBioFire Diagnostics, LLC device recall (Cls II)

    BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit) — Reason: Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat, 5 mm, 35 cm, Front-Actuated Grip Type S — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat, 5 mm, 45 cm Front-Actuated Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat, 5 mm, 35 cm, Inline Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat, 5 mm, 45 cm Inline Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 22, 2025device recall297d agoOlympus Corporation of the Americas device recall (Cls II)

    Olympus Thunderbeat 5 mm, 20 cm, Front-Actuated Grip — Reason: Firm is initiating a removal due to continued reports of adverse events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Oct 23, 2025approval296d agoVORICONAZOLE — FDA approvalVORICONAZOLE

    Sponsor: CADILA. Form: TABLET. Route: ORAL

    full page →VORICONAZOLE →fda approvals ↗
    ›Oct 23, 2025approval296d agoOMVOH (MIRIKIZUMAB-MRKZ) — FDA approvalmirikizumab

    Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →mirikizumab →fda approvals ↗
    ›Oct 23, 2025approval296d agoJAVADIN (CLONIDINE HYDROCHLORIDE) — FDA approvalclonidine hydrochloride

    Sponsor: AZURITY. Form: SOLUTION. Route: ORAL

    full page →clonidine hydrochloride →fda approvals ↗
    ›Oct 23, 2025approval296d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Oct 23, 2025approval296d agoDALBAVANCIN HYDROCHLORIDE — FDA approvalFresenius Kabi USA LLC

    Sponsor: TEVA PHARMS INC. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Oct 23, 2025approval296d agoVORICONAZOLE — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 23, 2025approval296d agoBLENREP (BELANTAMAB MAFODOTIN-BLMF) — FDA approvalbelantamab mafodotin

    Sponsor: GLAXOSMITHKLINE LLC. Form: INJECTABLE. Route: INJECTION

    full page →belantamab mafodotin →fda approvals ↗
    ›Oct 23, 2025approval296d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: RISING. Form: INJECTABLE. Route: INJECTION

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Oct 23, 2025approval296d agoDEHYDRATED ALCOHOL — FDA approval

    Sponsor: ROYAL PHARMS. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Oct 23, 2025approval296d agoDESIPRAMINE HYDROCHLORIDE — FDA approvalDESIPRAMINE HYDROCHLORIDE

    Sponsor: INGENUS PHARMS LLC. Form: TABLET. Route: ORAL

    full page →DESIPRAMINE HYDROCHLORIDE →fda approvals ↗
    ›Oct 23, 2025approval296d agoDOCOSANOL — FDA approvalPL Developments Copiague LLC

    Sponsor: DR REDDYS. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Oct 23, 2025approval296d agoQUINAPRIL HYDROCHLORIDE — FDA approvalLupin Ltd

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 23, 2025approval296d agoQUINAPRIL HYDROCHLORIDE — FDA approvalLupin Ltd

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 23, 2025approval296d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Oct 23, 2025approval296d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: AUROBINDO PHARMA. Form: SOLUTION. Route: ORAL

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Oct 23, 2025approval296d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: ACTAVIS LABS FL. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 23, 2025approval296d agoTOPIRAMATE — FDA approvalLP Pharmaceutical (Xiamen) Co Ltd

    Sponsor: ACTAVIS LABS FL. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 23, 2025device 510k296d agoVivasure Medical Limited — PerQseal Introducers (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 15 of 286
    next →
    $TMDX69.43-2.72%
    $LCTC
    $BSX51.83+0.27%
    $BSX51.83+0.27%
    $LCTC
    $MDT91.27+0.76%
    $TMDX69.43-2.72%
    $BSX51.83+0.27%
    $INSP42.44+0.38%
    $BSX51.83+0.27%
    $BSX51.83+0.27%
    $LCTC
    $LCTC
    $LLY1180.16-2.25%
    $RDY12.27-1.21%